Authors | Year | n | Complication | Technique | AL detection | Value (POD) | Cut-off | SN | SP | AUC |
---|---|---|---|---|---|---|---|---|---|---|
Deitmar [10] | 2009 | 558 | AL | Transthoracic | 8th POD (range, 2–16) | CRP (2) WBCC (8) | 135 mg/l 10.5/nl | > 80 > 70 | n/a n/a | n/a n/a |
Dutta [14] | 2011 | 136 | AL | Transhiatal, transthoracic | 6th POD (range, 2–13) | CRP (3) CRP (4) | 180 mg/l 180 mg/l | 82 71 | 63 83 | 0.81 0.86 |
Van Genderen [16] | 2011 | 63 | AL, cardiorespiratory, infections | Transthoracic | n/a | CRP (1) CRP (2) CRP (3) | 108.5 mg/l 175 mg/l 179 mg/l | 82 85 89 | 50 53 50 | 0.74 0.78 0.75 |
Warschkow [12] | 2011 | 210 | AL, pneumonia, UTI, central line infection, and others | Transhiatal, transthoracic | 7th POD (range, 4–11.3) | CRP (4) CRP (7) | 141 mg/l 162 mg/l | 78 56 | 70 89 | 0.77 0.81 |
Noble [34] | 2012 | 258 | AL | Transhiatal, transthoracic, cervical | 7th POD (range, 5–15) | CRP (4) CRP (5) WBCC (5) NUn score | 180 mg/l 189 mg/l 9/nl > 10 | 75 78 78 95 | 47 63 58 49 | 0.69 0.75 0.72 0.8 |
Tsujimoto [33] | 2012 | 61 | AL | Transthoracic | 7th POD (range, 5–12) | SIRS (4) | SIRS criteria* | 73 | 71 | 0.72 |
Hoeboer [18] | 2015 | 45 | AL | Transthoracic, transhiatal | n/a | CRP (3) ΔCRP (3–0) PCT (3) | 229 mg/l Δ55 mg/l 0.35 ng/ml | 71 80 67 | 84 80 80 | 0.78 0.82 0.86 |
Baker [35] | 2015 | 100 | AL | Transthoracic | n/a | WBCC (1 to 10) | > 12/nl | 92 | 34 | n/a |
Edagawa [44] | 2015 | 108 | AL | n/a | 8th POD | CRP (3) | 8.62 mg/dl | n/a | n/a | n/a |
Findlay [15] | 2015 | 248 | AL | Transthoracic | 7th POD (range, 3–18) | NUn score WBCC (4) | > 10 6.89/nl | 0 94 | 94 21 | 0.49 0.64 |
Gordon [17] | 2016 | 145 | AL | Transthoracic | 6th POD (range, 4–10) | CRP (2) CRP (3) CRP (6) | 209 mg/l 190 mg/l 154 mg/l | 100 100 100 | 61 59 78 | 0.82 0.8 0.91 |
Park [19] | 2017 | 201 | AL | Transthoracic | n/a | CRP(NT−) (3) CRP(NT+) (3) | 171 mg/l 164 mg/l | 69 80 | 78 70 | 0.82 0.71 |
Paireder [20] | 2017 | 258 | AL | Transhiatal, transthoracic | 9th POD (range, 1–23) | NUn score | > 10 | 45 | 74 | 0.59 |
Asti [36] | 2017 | 243 | AL | Transthoracic, cervical | 6th POD (n/a) | CRP (5) WBCC (5) PCT (5) | 83 mg/l 8.9/nl 0.38 ng/ml | 89 59 78 | 61 84 71 | 0.82 0.69 0.75 |
Nilsson [39] | 2018 | 462 | AL | Transthoracic, cervical | n/a | CRP (3) CRP (4) | 221 mg/l 203 mg/l | 59 57 | 83 82 | 0.75 0.73 |
Gao [37] | 2019 | 96 | AL | Transthoracic | n/a | Prealbumin (5) | 128 g/l | 100 | 50 | n/a |
Bundred [38] | 2020 | 382 | AL | Transthoracic, cervical | 8th POD (n/a) | NUn score | > 10 | 73 | 65 | 0.77 |
Liesenfeld (present study) | 2020 | 233 | AL | Transthoracic | 7th POD (range, 1–30) | WBC (4) CRP (4) NUn score | 8/nl 145 mg/l > 9 | 64 68 49 | 58 63 68 | 0.67 0.65 0.68 |